Jeremy Robinson is an experienced securities litigator, a fierce advocate for investor rights, and has dedicated his career to fighting corporate misconduct. He has been involved in prosecuting many high-profile securities cases and has obtained some of the largest investor recoveries in history.
Highlights of Jeremy’s trial experience include the following:
- Jeremy was an integral member of the team that recently achieved a significant victory at trial for investors in the In re Fannie Mae/Freddie Mac Senior Preferred Stock Purchase Agreement Class Action Litigations, No. 13-mc-01288 (D.D.C.). Jeremy and his colleagues successfully obtained a rare verdict for plaintiffs, which awarded shareholders $612 million in damages against the U.S. Federal Housing Finance Agency.
- He played a leading role in the In re Citigroup, Inc. Bond Action Litigation, which concerned inter alia toxic mortgage-backed securities and the 2008-09 financial crisis. The case settled before trial for $730 million, representing one of the largest recoveries ever in a securities class action brought on behalf of purchasers of debt securities and ranking among the top twenty-five largest recoveries in the history of securities class actions.
- He played a key role in the team that prosecuted In re Allergan Proxy Violation Securities Litigation, which concerned allegations of an unprecedented insider-trading scheme. After a hard-fought three-year legal battle, the case settled on the eve of trial for $250 million.
- Jeremy was a member of the teams that prosecuted In re Refco Securities Litigation (total recoveries in excess of $425 million); In re WellCare Health Plans, Inc. Securities Litigation ($200 million settlement, representing the second largest settlement of a securities case in Eleventh Circuit history); and In re Bank of New York Mellon Corp. Forex Transactions Litigation, which settled for $180 million.
- Jeremy also helped prosecute the In re Freeport-McMoRan Derivative Litigation, which settled for a cash recovery of nearly $154 million plus corporate governance reforms.
In 2000-01, Jeremy received the prestigious Harold G. Fox Scholarship and spent a year working with barristers and judges in London, England. In 2005, Jeremy obtained his Master of Laws degree from Columbia Law School, where he was honored as a Harlan Fiske Stone Scholar.
Held in high regard throughout the securities field, Jeremy was recently named to Law360’s 2024 Securities Editorial Advisory Board. The board, comprised of thought leaders from across the securities arena, provides feedback on Law360’s coverage of securities-related matters and shapes future coverage. Jeremy has been repeatedly recognized as one of the “500 Leading Plaintiff Financial Lawyers” in America by Lawdragon and one of the top-rated securities litigation attorneys in New York City by Thomson Reuters’ Super Lawyers. He also was named a "Litigation Star" by Benchmark Litigation, where peers complimented Jeremy’s “aggressive, front-facing” approach to litigation.